Back to top
more

Fresenius Medical Care AG & Co. (FMS)

(Real Time Quote from BATS)

$23.39 USD

23.39
109,324

-1.03 (-4.22%)

Updated Aug 6, 2025 11:18 AM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

1-Strong Buy of 5 1        

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value B Growth B Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 40% (148 out of 246)

Industry: Medical - Instruments

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

Zacks Value Investor Highlights: Alaska Air, Heidrick & Struggles, USANA Health Sciences, General Motors and Fresenius Medical Care

by Zacks Equity Research

Alaska Air, Heidrick & Struggles, USANA Health Sciences, General Motors and Fresenius Medical Care have been highlighted in this Value Investor article.

Tracey Ryniec headshot

5 Classic Value Stocks for 2025

by Tracey Ryniec

These stocks are cheap and have top Zacks Ranks of Strong Buy or Buy.

Zacks Equity Research

Why This 1 Value Stock Could Be a Great Addition to Your Portfolio

by Zacks Equity Research

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Zacks Equity Research

Fresenius (FMS) Upgraded to Strong Buy: Here's What You Should Know

by Zacks Equity Research

Fresenius (FMS) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Zacks Equity Research

Best Income Stocks to Buy for January 7th

by Zacks Equity Research

PRMB, FMS and RBA made it to the Zacks Rank #1 (Strong Buy) income stocks list on January 7, 2024.

Zacks Equity Research

Best Value Stocks to Buy for January 7th

by Zacks Equity Research

FMS, SVM and CNO made it to the Zacks Rank #1 (Strong Buy) value stocks list on January 7, 2024.

Zacks Equity Research

Best Momentum Stocks to Buy for December 27th

by Zacks Equity Research

PAYO, TTDKY and FMS made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on December 27, 2024.

Zacks Equity Research

Best Income Stocks to Buy for December 27th

by Zacks Equity Research

TTDKY, FMS and FHB made it to the Zacks Rank #1 (Strong Buy) income stocks list on December 27, 2024.

Zacks Equity Research

Best Value Stocks to Buy for December 27th

by Zacks Equity Research

AAL, FMS and TTDKY made it to the Zacks Rank #1 (Strong Buy) value stocks list on December 27, 2024.

Zacks Equity Research

Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick

by Zacks Equity Research

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Zacks Equity Research

AxoGen, Inc. (AXGN) Hits Fresh High: Is There Still Room to Run?

by Zacks Equity Research

AxoGen (AXGN) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Zacks Equity Research

Zacks.com featured highlights Tyson Foods, General Motors, Fresenius Medical Care and Deluxe

by Zacks Equity Research

Tyson Foods, General Motors, Fresenius Medical Care and Deluxe have been highlighted in this Screen of The Week article.

Sumit Singh headshot

4 Value Stocks to Buy as Wall Street Awaits Fed's Rate Decision

by Sumit Singh

Value investing is essentially about selecting stocks that are usually cheap but fundamentally sound. TSN, GM, FMS and DLX boast a low P/CF ratio.

Kinjel Shah headshot

5 Low Price-to-Book Value Stocks to Buy as 2024 Draws to a Close

by Kinjel Shah

The P/B ratio helps to identify low-priced stocks with high growth prospects. GM, FMS, CIO, TRTX and ZIM are some such stocks.

Zacks Equity Research

Leadership in Dialysis Services and Products Drives FMS Stock

by Zacks Equity Research

Fresenius Medical Care leads global dialysis services, driving growth through innovation, restructuring and a strong global footprint in 120+ countries.

Zacks Equity Research

Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio

by Zacks Equity Research

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Zacks Equity Research

Tandem Diabetes Care (TNDM) Down 9.2% Since Last Earnings Report: Can It Rebound?

by Zacks Equity Research

Tandem Diabetes Care (TNDM) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Zacks Equity Research

Are Investors Undervaluing Fresenius Medical Care AG & Co. (FMS) Right Now?

by Zacks Equity Research

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Zacks Equity Research

Here's Why Fresenius (FMS) is a Strong Value Stock

by Zacks Equity Research

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Zacks Equity Research

Tactile Systems Technology, Inc. (TCMD) Hit a 52 Week High, Can the Run Continue?

by Zacks Equity Research

Tactile Systems Technology (TCMD) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Zacks Equity Research

Why Fresenius (FMS) is a Top Value Stock for the Long-Term

by Zacks Equity Research

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Zacks Equity Research

Is Fresenius Medical Care AG & Co. (FMS) Stock Undervalued Right Now?

by Zacks Equity Research

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Zacks Equity Research

Fresenius Medical Q3 Earnings Beat Estimates, Operating Margin Rises

by Zacks Equity Research

FMS' third-quarter results showcase a strong segmental performance. The company raises its full-year 2024 outlook for operating income.

Zacks Equity Research

Fresenius (FMS) is a Top-Ranked Momentum Stock: Should You Buy?

by Zacks Equity Research

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Zacks Equity Research

Waters Stock Gains on Earnings & Sales Beat in Q3, Raised View

by Zacks Equity Research

WAT's third-quarter 2024 results show growth in the pharma and industrial sectors. A dip in China sales creates headwinds.